https://business.siften.com/novartis-trial-setbacks-turn-biotech-deal-risk-into-a-board-accountability-test-1789103751891 Siften Business en 2026-09-11T05:17:31.799+00:00 Novartis trial setbacks turn biotech deal risk into board accountability test https://business.siften.com/nubank-s-u-s-launch-tests-whether-an-emerging-market-fintech-can-compete-in-matu-1789103467471 Siften Business en 2026-09-11T05:13:10.647+00:00 Nubank’s U.S. launch tests its emerging-market playbook in a mature banking system https://business.siften.com/eutelsat-turns-europe-s-secure-connectivity-push-into-a-decade-long-oneweb-build-1789103178613 Siften Business en 2026-09-11T05:08:19.260+00:00 Eutelsat turns Europe’s secure-connectivity agenda into long-term OneWeb buildout https://business.siften.com/goodwin-s-1-1-billion-cerberus-deal-shows-scarcity-value-in-defense-manufacturin-1789016757102 Siften Business en 2026-09-10T05:07:54.953+00:00 Goodwin’s £1.1 Billion Cerberus Deal Highlights Scarcity Value in Defense Manufacturing